Citation Impact
Citing Papers
The 2.6 Angstrom Crystal Structure of a Human A 2A Adenosine Receptor Bound to an Antagonist
2008 StandoutScience
TCMSP: a database of systems pharmacology for drug discovery from herbal medicines
2014 Standout
G Protein-coupled Receptor Kinases Phosphorylate LRP6 in the Wnt Pathway
2009 StandoutNobel
Health care-associated infections – an overview
2018 Standout
Non-motor symptoms of Parkinson's disease: diagnosis and management
2006 Standout
Understanding the molecular basis of Alzheimer’s disease using a Caenorhabditis elegans model system
2009
An update on the mechanisms of the psychostimulant effects of caffeine
2007
Lobeline Attenuates Methamphetamine-Induced Changes in Vesicular Monoamine Transporter 2 Immunoreactivity and Monoamine Depletions in the Striatum
2004
G Protein-Coupled Receptor Kinase Function Is Essential for Chemosensation in C. elegans
2004 StandoutNobel
Non-motor symptoms of Parkinson's disease: dopaminergic pathophysiology and treatment
2009 Standout
Levodopa‐induced modulation of subthalamic beta oscillations during self‐paced movements in patients with Parkinson's disease
2005
Natural products: An evolving role in future drug discovery
2011 Standout
GRKs and β-arrestins: roles in receptor silencing, trafficking and signaling
2006 StandoutNobel
Ageing as a risk factor for neurodegenerative disease
2019 Standout
A Systematic Prediction of Multiple Drug-Target Interactions from Chemical, Genomic, and Pharmacological Data
2012
Mechanisms of neurotransmitter release by amphetamines: A review
2005 Standout
Herbal Extracts and Phytochemicals: Plant Secondary Metabolites and the Enhancement of Human Brain function
2011 Standout
The Pharmacology and Clinical Pharmacology of 3,4-Methylenedioxymethamphetamine (MDMA, “Ecstasy”)
2003 Standout
Double Dissociation of Dopamine Genes and Timing in Humans
2011
Vesicular monoamine transporter 2: Role as a novel target for drug development
2006
Illicit dopamine transients: Reconciling actions of abused drugs
2014
The Physiology, Signaling, and Pharmacology of Dopamine Receptors
2011 Standout
Pathophysiological distortions in time perception and timed performance
2011 Standout
An Akt/β-Arrestin 2/PP2A Signaling Complex Mediates Dopaminergic Neurotransmission and Behavior
2005 StandoutNobel
Impact of psychostimulants on vesicular monoamine transporter function
2003
Caffeine (1, 3, 7‐trimethylxanthine) in Foods: A Comprehensive Review on Consumption, Functionality, Safety, and Regulatory Matters
2010 Standout
Brief, repeated exposure to substrates down‐regulates dopamine transporter function in Xenopus oocytes in vitro and rat dorsal striatum in vivo
2002
Methamphetamine toxicity and messengers of death
2009
Non-motor features of Parkinson disease
2017 Standout
Dopaminergic Supersensitivity in G Protein-Coupled Receptor Kinase 6-Deficient Mice
2003 StandoutNobel
Rapid regulation of the dopamine transporter: role in stimulant addiction?
2004
Dopamine in Motivational Control: Rewarding, Aversive, and Alerting
2010 Standout
Depression in Parkinson's disease: loss of dopamine and noradrenaline innervation in the limbic system
2005
Neurobiology of addiction: a neurocircuitry analysis
2016 Standout
Chimeric antigen receptor T-cell therapy — assessment and management of toxicities
2017 Standout
Selective Inhibition of Hypoxia-Inducible Factor (HIF) Prolyl-Hydroxylase 1 Mediates Neuroprotection against Normoxic Oxidative Death via HIF- and CREB-Independent Pathways
2009 StandoutNobel
Oligomerization of Dopamine Transporters Visualized in Living Cells by Fluorescence Resonance Energy Transfer Microscopy
2003
Artificial intelligence in drug discovery and development
2020 Standout
DEPARTMENT OF HEALTH & HUMAN SERVICES
2015
Increased Acute Inflammation, Leukotriene B4-Induced Chemotaxis, and Signaling in Mice Deficient for G Protein-Coupled Receptor Kinase 6
2003 StandoutNobel
Different G protein-coupled receptor kinases govern G protein and β-arrestin-mediated signaling of V2 vasopressin receptor
2005 StandoutNobel
Enhanced Rewarding Properties of Morphine, but not Cocaine, in βarrestin-2 Knock-Out Mice
2003 StandoutNobel
Functional antagonism of different G protein-coupled receptor kinases for β-arrestin-mediated angiotensin II receptor signaling
2005 StandoutNobel
Frequency Dependence of Signal Power and Spatial Reach of the Local Field Potential
2013 Standout
DESENSITIZATION OF G PROTEIN–COUPLED RECEPTORS AND NEURONAL FUNCTIONS
2004 StandoutNobel
Works of Verónica Sandoval being referenced
Methylphenidate Alters Vesicular Monoamine Transport and Prevents Methamphetamine-Induced Dopaminergic Deficits
2003
Psychostimulants and Vesicle Trafficking: A Novel Mechanism and Therapeutic Implications
2004
A Single Methamphetamine Administration Rapidly Decreases Vesicular Dopamine Uptake
2002
Methylenedioxymethamphetamine Decreases Plasmalemmal and Vesicular Dopamine Transport: Mechanisms and Implications for Neurotoxicity
2002
Methamphetamine decreases mouse striatal dopamine transporter activity: roles of hyperthermia and dopamine
2000
Inhibitory effect of reserpine on dopamine transporter function
2002
Methamphetamine-Induced Rapid and Reversible Changes in Dopamine Transporter Function: AnIn VitroModel
2001
Methamphetamine-induced rapid and reversible changes in dopamine transporter function: an in vitro model.
2001
Methylphenidate Redistributes Vesicular Monoamine Transporter-2: Role of Dopamine Receptors
2002